Chapter 1 - In what Setting Should Women with Ovarian Cancer Receive Care?
Chapter 2 - Quality of Life in Ovarian Cancer Treatment and Survivorship
Chapter 3 - Preventive Strategies for Ovarian Cancer
Chapter 4 - Borderline Epithelial Tumors of the Ovary
Chapter 5 - Implication of Clear Cell and Mucinous Histology
Chapter 6 - Demographic and Clinical Characteristics of Mucinous Epithelial Ovarian Cancer, and Survival Following a Mucinous Epithelial Ovarian Cancer Diagnosis
Chapter 7 - The Genetics of Ovarian Cancer
Chapter 8 - Surgical Treatment of Ovarian Cancer
Chapter 9 - The Role of Chemotherapy in Recurrent Ovarian Cancer
Chapter 10 - Molecular Mechanisms of Platinum Resistance in Ovarian Cancer
Chapter 11 - Biological Significance of Apoptosis in Ovarian Cancer: TRAIL Therapeutic Targeting
Chapter 12 - Protein Kinase G-I? Hyperactivation and VASP Phosphorylation in Promoting Ovarian Cancer Cell Migration and Platinum Resistance
Chapter 13 - The PI3K/Akt/mTOR Pathway in Ovarian Cancer: Biological Rationale and Therapeutic Opportunities
Chapter 14 - PARP Inhibitors in Ovarian Cancer
Chapter 15 - The Merit of Alternative Messenger RNA Splicing as a New Mine for the Next Generation Ovarian Cancer Biomarkers
Chapter 16 - Ovarian Cancer in vitro Diagnostics: New Approaches to Earlier Detection
Chapter 17 - Disseminated Tumor Cells and Cancer Stem Cells in Ovarian Cancer
